阿库斯生物科学 RCUS
$18.28 +$0.59 (+3.34%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $18.28 0.00%
开盘$17.95
昨收$17.69
当日区间$17.51 – $18.50
成交量1.06M
市值$2.63B
市盈率（TTM）–
股息率–
财报
财报日平均波动±4.5%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+19.9%
最差反应-4.3%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±13.3% | +2.27% | 符合区间 |
| 2026/Q1 | 5 May 2026 | After Market | ±17.7% | -0.23% | 符合区间 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±24.3% | -3.60% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±28.4% | -2.21% | 符合区间 |
| 2025/Q1 | 6 May 2025 | After Market | ±15.4% | -1.35% | 符合区间 |
| 2024/Q4 | 25 Feb 2025 | After Market | ±14.6% | -0.98% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±23.2% | +4.64% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | ±17.9% | +14.02% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±12.3% | +5.83% | 符合区间 |
| 2023/Q4 | 21 Feb 2024 | After Market | ±17.7% | +19.87% | 超出定价预期 |
| 2023/Q3 | 7 Nov 2023 | After Market | ±17.4% | -2.67% | 符合区间 |
| 2023/Q2 | 7 Aug 2023 | Pre Market | ±15.4% | -4.26% | 符合区间 |
| 2023/Q1 | 9 May 2023 | After Market | ±16.3% | -3.04% | 符合区间 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±13.7% | -4.34% | 符合区间 |
| 2022/Q3 | 2 Nov 2022 | After Market | ±26.6% | -0.45% | 符合区间 |
| 2022/Q2 | 3 Aug 2022 | After Market | ±27.0% | +1.90% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$41.00M-74.4% YoY
营业利润-$96.00M-1,100.0% YoY
净利润-$91.00M
摊薄每股收益-$0.72
自由现金流-$119.00M+10.5% YoY
经营现金流-$119.00M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
营业利润率-415.4%
净利率-393.2%
净资产收益率-90.8%
资产收益率-46.0%
投入资本回报率-78.6%
流动比率3.82
负债/资产比率49.8%
现金及投资$702.00M
总负债$101.00M
净现金（净负债）$601.00M
暂无评论——快来第一个聊聊 RCUS。
登录后参与讨论。